RICHARD WILLIAMS: Open Payments
NPI 1427634229 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 38 payments from 9 companies in 2025. Trend: 2023 $1,337 · 2024 $1,258 · 2025 $1,923
Food & beverage: $1,823Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $599 |
| E.R. Squibb & Sons, L.L.C. | 6 | $452 |
| Alkermes, Inc. | 2 | $220 |
| Axsome Therapeutics, Inc. | 2 | $184 |
| Janssen Pharmaceuticals, Inc | 2 | $162 |
| Otsuka America Pharmaceutical, Inc. | 1 | $103 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Lundbeck LLC | 4 | $90 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, COBENFY, LYBALVI, REXULTI, Auvelity, INVEGA SUSTENNA, INGREZZA.
Industry payments across NH — which companies pay providers there.
